Press Releases 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Eagle Pharmaceuticals Announces Positive Results of Pre-clinical Study Conducted to Evaluate Effects of RYANODEX in Acute Radiation Syndrome (ARS) 11/27/18 Eagle Pharmaceuticals, Inc. to Present at 30th Annual Piper Jaffray Healthcare Conference 11/19/18 Eagle Pharmaceuticals, Inc. Reports Third Quarter 2018 Results 11/1/18 Eagle Pharmaceuticals Commences $50 Million Accelerated Share Repurchase as Part of New $150 Million Share Repurchase Authorization 10/30/18 Eagle Pharmaceuticals Announces Results of Study for Fulvestrant 10/30/18 Eagle Pharmaceuticals, Inc. to Discuss Third Quarter 2018 Financial Results on November 1, 2018 10/25/18 Eagle Pharmaceuticals Enters into Agreement with USAMRICD to Evaluate Neuroprotective Effects of RYANODEX Secondary to Nerve Agent Exposure 10/3/18 Eagle Pharmaceuticals, Inc. To Present At Cantor Global Healthcare Conference 9/27/18 Eagle Appoints David Pernock to Position of Chief Operating Officer 9/26/18 Eagle Pharmaceuticals, Inc. to Present at Morgan Stanley 16th Annual Global Healthcare Conference 9/4/18 Pagination Current page 1 Page 2 Page 3 Next page Last page
